Irsogladine is a mucosal protective agent and selective 5-lipoxygenase inhibitor primarily utilized in the treatment of gastric ulcers and various peptic ulcer diseases by enhancing gastrointestinal mucosal… Read more











Irsogladine is a mucosal protective agent and selective 5-lipoxygenase inhibitor primarily utilized in the treatment of gastric ulcers and various peptic ulcer diseases by enhancing gastrointestinal mucosal defense mechanisms. This category provides access to high-quality reference standards for Irsogladine, including its active pharmaceutical ingredient, identified degradation products, and related chemical impurities. Analytical laboratories require these precise materials for impurity profiling, method validation, and rigorous quality control protocols during pharmaceutical manufacturing. Additionally, stable isotope labelled compounds, such as deuterium-labelled Irsogladine, are essential for researchers performing quantification studies, particularly when using liquid chromatography-mass spectrometry (LC-MS) to track metabolic pathways or monitor active substance levels. By utilizing this comprehensive collection of reference materials, scientists can ensure accurate detection and reliable testing across all stages of drug development and safety evaluation for this therapeutic compound.